Nuvectra Corp Cmn ST (NVTR) 6.61 $NVTR Nuvectra
Post# of 273242
Posted On: 09/19/2016 11:01:49 PM
Nuvectra Corp Cmn ST (NVTR) 6.61 $NVTR
Nuvectra Reports Second Quarter 2016 Financial Results
GlobeNewswire - Wed Aug 10, 3:01PM CDT
Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today financial results for the second quarter ended July 1, 2016.
NVTR: 6.61 (-0.06)
Medical Products' Earnings on Aug 10: PRGO, NVTR & BSGM
Zacks Equity Research - Zacks Investment Research - Tue Aug 09, 7:32AM CDT
The scorecard has so far exhibited a 4.1% year-over-year decline in second-quarter earnings on 0.9% lower revenues.
PRGO: 93.28 (-0.02), NVTR: 6.61 (-0.06)
Nuvectra Announces Formation of Medical Advisory Board
GlobeNewswire - Mon Aug 08, 7:00AM CDT
Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today the formation of the Nuvectra Medical Advisory Board ("MAB"
. The Nuvectra MAB is composed of three renowned experts in neurostimulation therapies and pain medicine. The MAB will serve as a key strategic resource for the Company as it commercializes the Algovita(R) Spinal Cord Stimulation System. The MAB will help guide the development of clinical study and marketing strategies, clinician education programs, and future pipeline initiatives.
NVTR: 6.61 (-0.06)
Integer (ITGR) Misses on Q2 Earnings, Synergy View Up
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 4:05PM CDT
Integer (ITGR) reported adjusted earnings of 56 cents per share in the second quarter of 2016, which missed the Zacks Consensus Estimate of 74 cents.
MASI: 59.84 (+0.50), ITGR: 21.58 (-0.12), NVTR: 6.61 (-0.06), CPHD: 52.56 (-0.04)
Nuvectra to Report Second Quarter 2016 Financial Results on August 10, 2016
GlobeNewswire - Wed Jul 27, 3:01PM CDT
Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that it will release its financial results for the second quarter ended July 1, 2016 on Wednesday, August 10, 2016 after the market close.
NVTR: 6.61 (-0.06)
Nuvectra Reports First Quarter 2016 Financial Results
GlobeNewswire - Wed May 11, 3:01PM CDT
Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today financial results for the first quarter ended April 1, 2016.
NVTR: 6.61 (-0.06)
Greatbatch (GB) Misses on Q1 Earnings & Sales, View Intact
Zacks Equity Research - Zacks Investment Research - Thu May 05, 8:27AM CDT
Greatbatch Inc. (GB) reported adjusted earnings of 34 cents per share in the first quarter of 2016, which plunged 47.7% from the year-ago quarter.
IRMD: 17.10 (-0.42), GB: 30.93 (+0.63), NVTR: 6.61 (-0.06), EW: 116.74 (+0.14)
Greatbatch, Inc. Reports 2016 First Quarter Results
GlobeNewswire - Thu Apr 28, 3:06PM CDT
Greatbatch, Inc. (NYSE:GB), today announced results for its first quarter ended April 1, 2016.
GB: 30.93 (+0.63), NVTR: 6.61 (-0.06)
Nuvectra to Report First Quarter 2016 Financial Results on May 11, 2016
GlobeNewswire - Tue Apr 26, 3:01PM CDT
Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that it will release its financial results for the first quarter ended April 1, 2016, on Wednesday, May 11, 2016 after the market close.
NVTR: 6.61 (-0.06)
Oxford Finance and Silicon Valley Bank Close $45 Million Credit Facility with Nuvectra
PR Newswire - Thu Apr 21, 12:00PM CDT
Oxford Finance LLC ("Oxford", a specialty finance firm that provides senior debt to life sciences and healthcare services companies, and Silicon Valley Bank, the bank of the world's most innovative companies and their investors, today announced the closing of a $45 million term loan to Nuvectra Corporation ("the Company" or "Nuvectra". The facility is comprised of a $40 million senior secured term loan and a $5 million line of credit. Funds are being used to finance the Company's recent spin-off from its parent company, Greatbatch, Inc., and to establish a market presence in the United States for its first product, Algovita®.
GB: 30.93 (+0.63), NVTR: 6.61 (-0.06)
Nuvectra Reports Second Quarter 2016 Financial Results
GlobeNewswire - Wed Aug 10, 3:01PM CDT
Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today financial results for the second quarter ended July 1, 2016.
NVTR: 6.61 (-0.06)
Medical Products' Earnings on Aug 10: PRGO, NVTR & BSGM
Zacks Equity Research - Zacks Investment Research - Tue Aug 09, 7:32AM CDT
The scorecard has so far exhibited a 4.1% year-over-year decline in second-quarter earnings on 0.9% lower revenues.
PRGO: 93.28 (-0.02), NVTR: 6.61 (-0.06)
Nuvectra Announces Formation of Medical Advisory Board
GlobeNewswire - Mon Aug 08, 7:00AM CDT
Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today the formation of the Nuvectra Medical Advisory Board ("MAB"
. The Nuvectra MAB is composed of three renowned experts in neurostimulation therapies and pain medicine. The MAB will serve as a key strategic resource for the Company as it commercializes the Algovita(R) Spinal Cord Stimulation System. The MAB will help guide the development of clinical study and marketing strategies, clinician education programs, and future pipeline initiatives. NVTR: 6.61 (-0.06)
Integer (ITGR) Misses on Q2 Earnings, Synergy View Up
Zacks Equity Research - Zacks Investment Research - Tue Aug 02, 4:05PM CDT
Integer (ITGR) reported adjusted earnings of 56 cents per share in the second quarter of 2016, which missed the Zacks Consensus Estimate of 74 cents.
MASI: 59.84 (+0.50), ITGR: 21.58 (-0.12), NVTR: 6.61 (-0.06), CPHD: 52.56 (-0.04)
Nuvectra to Report Second Quarter 2016 Financial Results on August 10, 2016
GlobeNewswire - Wed Jul 27, 3:01PM CDT
Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that it will release its financial results for the second quarter ended July 1, 2016 on Wednesday, August 10, 2016 after the market close.
NVTR: 6.61 (-0.06)
Nuvectra Reports First Quarter 2016 Financial Results
GlobeNewswire - Wed May 11, 3:01PM CDT
Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today financial results for the first quarter ended April 1, 2016.
NVTR: 6.61 (-0.06)
Greatbatch (GB) Misses on Q1 Earnings & Sales, View Intact
Zacks Equity Research - Zacks Investment Research - Thu May 05, 8:27AM CDT
Greatbatch Inc. (GB) reported adjusted earnings of 34 cents per share in the first quarter of 2016, which plunged 47.7% from the year-ago quarter.
IRMD: 17.10 (-0.42), GB: 30.93 (+0.63), NVTR: 6.61 (-0.06), EW: 116.74 (+0.14)
Greatbatch, Inc. Reports 2016 First Quarter Results
GlobeNewswire - Thu Apr 28, 3:06PM CDT
Greatbatch, Inc. (NYSE:GB), today announced results for its first quarter ended April 1, 2016.
GB: 30.93 (+0.63), NVTR: 6.61 (-0.06)
Nuvectra to Report First Quarter 2016 Financial Results on May 11, 2016
GlobeNewswire - Tue Apr 26, 3:01PM CDT
Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that it will release its financial results for the first quarter ended April 1, 2016, on Wednesday, May 11, 2016 after the market close.
NVTR: 6.61 (-0.06)
Oxford Finance and Silicon Valley Bank Close $45 Million Credit Facility with Nuvectra
PR Newswire - Thu Apr 21, 12:00PM CDT
Oxford Finance LLC ("Oxford"
, a specialty finance firm that provides senior debt to life sciences and healthcare services companies, and Silicon Valley Bank, the bank of the world's most innovative companies and their investors, today announced the closing of a $45 million term loan to Nuvectra Corporation ("the Company" or "Nuvectra". The facility is comprised of a $40 million senior secured term loan and a $5 million line of credit. Funds are being used to finance the Company's recent spin-off from its parent company, Greatbatch, Inc., and to establish a market presence in the United States for its first product, Algovita®. GB: 30.93 (+0.63), NVTR: 6.61 (-0.06)
(0)
(0)Scroll down for more posts ▼